Advanced Cardiovascular Life Support (ACLS) Market

Advanced Cardiovascular Life Support (ACLS) Market Analysis

The Advanced Cardiovascular Life Support Market size is estimated at USD 8.5 billion in 2025, and is expected to reach USD 11.89 billion by 2030, at a CAGR of 8.77% during the forecast period (2025-2030).

ACLS (Advanced Cardiovascular Life Support) utilizes evidence-based medical procedures to manage life-threatening emergencies, such as cardiac arrest, stroke, and trauma. By adhering to structured algorithms, ACLS aims to stabilize patients and restore vital signs and alertness. Several factors, such as the rising prevalence of chronic cardiovascular conditions, and technological advancements are likely to drive the market growth. Additionally, a growing focus on early and effective cardiac care, supported by public awareness campaigns and training protocols, significantly contributes to market growth during the forecast period.

The advanced cardiovascular life support (ACLS) market is experiencing notable growth, fueled by high cardiac procedural volumes. The increasing prevalence of cardiovascular diseases, such as heart attacks, strokes, and arrhythmia, necessitates a higher demand for cardiac procedures like advanced airway management, defibrillation, etc. For instance, the German Heart Surgery Report 2023 shared insights from a voluntary registry maintained by the German Society for Thoracic and Cardiovascular Surgery (DGTHG). This registry reported 168,841 cardiovascular procedures conducted in 2023 in the country. Of these, 19,699 pacemaker and implantable cardioverter defibrillator procedures accounted for 99.2%. Additionally, 2,982 extracorporeal life support and extracorporeal membrane oxygenation implantations were recorded, highlighting the growing adoption of mechanical circulatory support systems. Hence, the high number of cardiac procedures is likely to drive the adoption of ACLS training and technologies in hospitals and clinics during the forecast period.

Furthermore, major players are swiftly embracing cutting-edge strategies, including the adoption of novel technologies, a move expected to propel market expansion. For instance, in September 2024, Apollo Hospitals in Hyderabad, India, successfully treated the first-ever survivor of the E-CPR (extracorporeal cardiopulmonary resuscitation) procedure. E-CPR employs ECMO (extracorporeal membrane oxygenation), a vital technique that temporarily takes over the functions of both the heart and lungs. The availability of advanced technologies within cardiovascular care is expected to boost the growth of the market in the coming years.

Therefore, owing to factors such as increasing prevalence of cardiovascular diseases and advancements in medical technology, the advanced cardiovascular life support market is anticipated to witness significant growth over the forecast period. However, the high cost of ACLS devices and training, lack of skilled professionals, and low accessibility in low-income countries are expected to limit the market growth.

Advanced Cardiovascular Life Support (ACLS) Market Trends

Cardiopulmonary Resuscitation (CPR) Segment is Expected to Witness Significant Growth Over the Forecast Period

Cardiopulmonary resuscitation (CPR) is performed to keep the supply of oxygenated blood through the body until the heart can perform this function on its own. Multiple factors, such as increased public awareness, emphasis on early intervention, advancements in CPR devices, evolving guidelines, and government support for training initiatives, etc., are contributing to the growth of the segment.

According to research published in the Journal of the American Heart Association in May 2024, in the United States, about 72% of cardiac arrests that occur outside of a hospital happen at home. Furthermore, data from the British Heart Association in September 2024 estimated that 1 in 12 individuals globally is affected by heart or circulatory diseases. This number is likely to grow further due to factors such as shifting lifestyles, an aging population, and improved survival rates following heart attacks and strokes. These trends highlight the rising necessity for advanced cardiovascular life support (ACLS) like CPR, which is expected to drive segment growth during the forecast period.

Moreover, the rising emphasis on CPR training and education initiatives is anticipated to drive the adoption of CPR devices. As more individuals become certified in CPR, the demand for reliable devices, such as automated external defibrillators (AEDs) and other assistive technologies, is expected to grow. Thus, key players in the market are increasingly prioritizing collaborations as they emphasize enhancing the quality and accessibility of CPR training. For instance, in August 2024, MedLern announced a strategic collaboration with Aster CMI Hospital in Bangalore, India. This partnership aims to implement the Resuscitation Quality Improvement (RQI) Program from the American Heart Association (AHA). This program focuses on enhancing the readiness and effectiveness of hospital staff in critical care and emergencies through certifications in essential life support (ELS), advanced cardiovascular life support (ACLS), and pediatric advanced life support (PALS). This increased demand will further fuel the segment's growth within the advanced cardiovascular life support market.

Additionally, government initiatives, including public awareness campaigns and funding programs, significantly drive the adoption of CPR training, leading to improved survival rates for cardiac arrest victims. For example, in May 2023, the American Heart Association underscored the significance of CPR techniques, coinciding with the 49th Emergency Medical Services (EMS) Week, to bolster awareness for cardiovascular patients. These efforts are anticipated to drive significant growth in the CPR segment, thereby contributing to the overall expansion of the advanced cardiovascular life support market.

Hence, due to the above-mentioned factors such as increased public awareness, emphasis on early intervention, and advancements in CPR devices, the cardiopulmonary resuscitation (CPR) segment is expected to witness significant growth in the upcoming years.

North America is Expected to Dominate the Market Over the Forecast Period

North America is expected to dominate the market owing to factors such as a rising prevalence of cardiovascular diseases among its aging population, a robust healthcare infrastructure with advanced medical facilities, significant investments in research and development of new technologies, and a substantial healthcare budget that prioritizes advanced ACLS technologies and training.

Moreover, increasing efforts to improve out-of-hospital cardiac arrest outcomes drive demand in the advanced cardiovascular life support market. Centralized AED (Automated External Defibrillator) registries and broader public deployment highlight the importance of early defibrillation with CPR, boosting investments in AED technology and training initiatives. For instance, in October 2024, the Heart & Stroke Foundation recognized the Ontario government's proactive approach to advancing heart health systems. The province introduced its first Automated External Defibrillator (AED) registry in collaboration with the AED Foundation of Ontario. This initiative positions Ontario as a leader in developing comprehensive and coordinated heart health frameworks, with only a limited number of other provinces implementing similar registries. Such advancements are expected to create significant opportunities for market players in this region over the forecast period.

Moreover, with the rising prevalence of cardiovascular diseases (CVDs) in the region, there is an escalating demand for urgent medical interventions, notably Advanced Cardiovascular Life Support (ACLS). ACLS plays a pivotal role in addressing life-threatening cardiac emergencies, including heart attacks, strokes, and arrhythmias. As the patient count in need of these interventions grows, so does the market's potential. For instance, according to a report released by heart disease and stroke statistics in 2023, over 356,000 out-of-hospital cardiac arrests (OHCA) occurred in the United States, with 40.2% receiving bystander CPR. Furthermore, a June 2024 survey by the American Heart Association reported an average of 33 daily incidents of cardiac arrest and drownings in the U.S., with one-third resulting in fatalities. These figures emphasize the growing demand for advanced cardiovascular life support devices, driving market expansion.

Additionally, as public awareness grows, there will be greater demand for CPR training programs, equipment, and materials. Moreover, the need for advanced ACLS interventions, such as defibrillation, airway management, etc., will rise as more patients reach hospitals alive due to increased bystander CPR. This surge in demand for ACLS procedures is propelling market growth. For instance, in May 2024, the American Heart Association, Inc. launched a campaign in Los Angeles, coinciding with Asian American Native Hawaiian Pacific Islander Heritage Month (AANHPI). The campaign underscores the importance of being ready for cardiac emergencies. This initiative is part of the American Heart Association's broader "Nation of Lifesavers" movement, aiming to transform bystanders into lifesavers and double survival rates from sudden cardiac arrests by 2030. By aligning with this initiative, companies in the market can not only contribute to improving public health but also gain a competitive advantage in the market.

Therefore, owing to the factors mentioned above such as increasing prevalence of cardiovascular diseases among the aging population, a well-established healthcare infrastructure equipped with advanced medical facilities and significant investments in research and development of innovative technologies, the growth of the studied market is anticipated in the North American region.

Advanced Cardiovascular Life Support (ACLS) Industry Overview

The advanced cardiovascular life support (ACLS) market is fragmented in nature due to the presence of several companies operating globally as well as regionally. Leading companies shaping the advanced cardiovascular life support market include both global players and notable local firms. Key participants are developing and launching novel products and technologies to compete with existing products, while others are acquiring and partnering with other companies trending in the market. CPR Medical Devices, Inc., Abbott, and Michigan Instruments stand out as key players, collaborating with industry giants such as GE HealthCare, Nasco Healthcare Inc., and Boston Scientific Corporation. Furthermore, Koninklijke Philips N.V., Stryker, Asahi Kasei Corporation, ZOLL Medical Corporation, and Naugra Medical, among others, play a pivotal role in shaping the market landscape.

Advanced Cardiovascular Life Support (ACLS) Market Leaders

Advanced Cardiovascular Life Support (ACLS) Market News

• October 2024: Boston Scientific Corporation secured United States Food and Drug Administration (FDA) approval for its navigation-enabled FARAWAVE NAV Ablation Catheter, targeting the treatment of paroxysmal atrial fibrillation (AF). Additionally, the company received FDA 510(k) clearance for its new FARAVIEW Software. These innovations will enhance visualization during cardiac ablation procedures, working in tandem with the FARAPULSE Pulsed Field Ablation (PFA) System.
• October 2024: Abbott announced key progress in its pulsed field ablation (PFA) solutions, including the early completion of enrollment for the VOLT-AF IDE Study supporting the Volt PFA System and the launch of the FOCALFLEX trial to evaluate the TactiFlex Duo Ablation Catheter, Sensor Enabled (SE), for treating paroxysmal atrial fibrillation.